Health & Safety Industry Today

Cardiovascular Catheters Market to Reach US$ 71,797.6 Million by 2033 at 9.3% CAGR

According to BMI; The cardiovascular catheters market size is expected to reach US$ 71,797.6 million by 2033 from US$ 33,038.7 million in 2024. The market is estimated to record a CAGR of 9.3% from 2025 to 2033.
Published 01 April 2026

Leading companies in this market, such as Medtronic Plc, Abbott Laboratories, and Boston Scientific Corp., are focusing on product innovation, partnerships, and expanding into growth markets. As the demand for cardiovascular catheters continues to rise, manufacturers are developing more advanced products. This is expected to lead to a noticeable increase in the availability of cardiovascular catheters, ultimately reducing costs, enhancing effectiveness, and improving patient outcomes worldwide. This growth is also driven by the surging adoption of minimally invasive cardiac procedures and technological advancements in drug-eluting balloons, intravascular ultrasound (IVUS), and bioabsorbable catheters. Despite these positive trends, there are concerns related to the risks concerning catheter-related infections and complications, which may hinder the market's evolution.

Geographically, North America currently holds the largest share of the global Cardiovascular Catheters market, largely due to a high incidence of chronic diseases in the region. Meanwhile, the Asia Pacific is emerging as the fastest-growing market, driven by a combination of increasing chronic disease burden and rapid technological adoption.

Check valuable insights in the Cardiovascular Catheters Market report. You can easily get a sample PDF of the report - https://www.businessmarketinsights.com/sample/BMIPUB00031920

Segments Covered

By Product

  • Balloon Catheter
  • Diagnostic Catheter
  • Guiding Catheters
  • Ablation Catheter
  • IVUS Catheter
  • Others

By Coating Type

  • Coated Catheter
  • Uncoated Catheter

By Lumen

  • Single-lumen
  • Multi-lumen

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others

Cardiovascular Catheters Market Drivers and Opportunities:

Rising Prevalence of Cardiovascular Diseases Driving Cardiovascular Catheters Market

The surging worldwide incidence of cardiovascular diseases (CVDs) significantly drives the market for cardiovascular catheters. Also, CVDs, including coronary artery disease, heart failure, and arrhythmias, are major contributors to worldwide morbidity and mortality. They require advanced and often costly diagnostic and therapeutic techniques.

Cardiovascular catheters are thin, flexible tubes inserted into blood vessels to access the heart, making them crucial tools for many medical procedures. They play a vital role in diagnostic angiography, which detects blockages in the arteries, and in percutaneous coronary interventions (PCI), where they are used to perform balloon angioplasty and deploy stents to open narrowed arteries. Additionally, these catheters are essential in electrophysiology studies to assess and treat heart rhythm issues.

The demand for these catheters is further influenced by factors such as increasing age, obesity, diabetes, and a lack of physical activity. Cardiovascular catheters offer advantages such as shorter hospital stays, faster recovery times, and fewer complications as compared to traditional open-heart surgeries. The robust correlation between the growing heart disease incidences and the surging adoption of cardiovascular catheters highlights the increasing demand for CVD procedures, indicating significant growth potential for this market in the coming years.

Market leaders and key company profiles

  • Medtronic Plc
  • Boston Scientific Corp
  • Becton, Dickinson and Co
  • Teleflex Inc
  • B. Braun SE
  • Abbott Laboratories
  • Terumo Corp
  • Johnson & Johnson
  • Cook Medical Holdings LLC
  • Edward Lifesciences Corporation

Expansion into Emerging Markets

The expansion into emerging markets offers a huge opportunity for the players in the cardiovascular catheters market, driven by a combination of factors. Regions such as Asia-Pacific and Latin America are witnessing a rapid increase in cardiovascular diseases owing to urbanization, lifestyle changes, and an aging population. This surge in health issues has led to a growing number of patients requiring treatment.

Advancements in healthcare infrastructure have made it easier for patients to access care, while economic growth has increased disposable incomes, allowing more individuals to afford advanced medical treatments. The surging demand for surgical interventions, along with increased investments from both government and private sectors in healthcare facilities and services, creates a substantial opportunity for medical device companies to establish strategic partnerships with local distributors.

Effective strategies should involve collaboration with local manufacturers and the development of products that are more affordable and accessible to patients. By forming partnerships and investing in these regions, medical device companies can facilitate market growth, thereby diversify their revenue streams and ensure future growth in the medical device markets of North America and Europe.

Cardiovascular Catheters Market News and Key Development:

The cardiovascular catheters market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Cardiovascular Catheters market are:

  • Medtronic announced that its OmniaSecure defibrillation lead, a specialized, catheter-delivered lead, received FDA approval. This is noted as the world's smallest-diameter defibrillation lead, intended for implantation in the right ventricle to treat ventricular tachyarrhythmias and other cardiac conditions. The approval was based on data from the LEADR clinical trial. (Source: Medtronic, Company Website, April 2025)
  • Teleflex received Breakthrough Device Designation from the FDA for its Ringer Perfusion Balloon Catheter. This device is being studied for its use in managing coronary perforations, a serious complication that can occur during percutaneous coronary intervention (PCI). The designation highlights the device's potential to provide a more effective treatment option for this high-risk patient group. (Source: Becton Dickinson and Co, Press Release, March 2025)

Get Premium Research Report of Cardiovascular Catheters Market Size and Growth Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031920

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

  • If you have any questions about this report or would like further information, please contact us:
  • Contact person: Ankit Mathur
  • Email: sales@businessmarketinsights.com
  • Phone: +16467917070


 

Other Industry News

Ready to start publishing

Sign Up today!